SCA
TDOC icon

Spearhead Capital Advisors’s Teladoc Health TDOC Stock Holding History

Spearhead Capital Advisors’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,359
Closed -$308K – 225
2021
Q4 		$308K Sell
3,359
-362
-10% -$43.3K 0.04% 144
2021
Q3 		$472K Sell
3,721
-79
-2% -$11.5K 0.06% 104
2021
Q2 		$632K Buy
3,800
+801
+27% +$130K 0.09% 81
2021
Q1 		$545K Sell
2,999
-441
-13% -$102K 0.08% 80
2020
Q4 		$688K Buy
3,440
+144
+4% +$29.3K 0.11% 75
2020
Q3 		$723K Buy
3,296
+145
+5% +$30.7K 0.14% 65
2020
Q2 		$601K Sell
3,151
-402
-11% -$70.4K 0.13% 70
2020
Q1 		$551K Buy
+3,553
New +$413K 0.16% 73

Other funds holding TDOC

AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
KA
Kinnevik AB Stockholm, Sweden $65.6M AUM 25.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Spearhead Capital Advisors's TDOC Position: Q1 2022 in Review

Spearhead Capital Advisors sold out of Teladoc Health (TDOC) in Q1 2022, closing a stake of 3,359 shares — an estimated $308K sold.

Spearhead Capital Advisors first reported a position in TDOC in Q1 2020 and held it in 8 quarters. The position peaked at $723K in Q3 2020. 680 funds tracked by Wall St. Rank hold TDOC as of Q1 2022.

  • Spearhead Capital Advisors reported no remaining Teladoc Health position as of Q1 2022 after selling out during the quarter.
  • Spearhead Capital Advisors sold 3,359 Teladoc Health shares in Q1 2022, an estimated $308K.
  • Spearhead Capital Advisors first reported a position in Teladoc Health in Q1 2020 and held it in 8 quarters.
  • Spearhead Capital Advisors's Teladoc Health position peaked at $723K in Q3 2020.
  • 680 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2022.

Based on Spearhead Capital Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.